Inventor
JINQUAN LUO
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C12NMicroorganisms or enzymes8%
Y02ATechnologies for adaptation to climate change5%
PatentTitleYear
12,460,001Proteins comprising CD3 antigen binding domains and uses thereof202512,234,280Anti-PHF-tau antibodies and uses thereof202512,161,716Anti-IL-23 antibodies, compositions, methods and uses202412,084,501Proteins comprising CD3 antigen binding domains and uses thereof202412,077,585Proteins comprising kallikrein related peptidase 2 antigen binding domains and their uses202412,071,466Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereof202411,787,875Materials and methods for improved single chain variable fragments202311,746,161Antibodies that specifically bind PD-1 and methods of use202311,236,155Antibodies to pyroglutamate amyloid-b and uses thereof202211,185,584Anti-IL-23 antibodies, compositions, methods and uses2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to JANSSEN BIOTECH INC (8)· patent assignee history
2021–2025Based in US· patent location history
2022–2025Patents assigned to JANSSEN PHARMACEUTICA NV (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN BIOTECH INC | 8 | 2021–2025 |
| JANSSEN PHARMACEUTICA NV | 2 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2021–2025 |